JLE

Epileptic Disorders

MENU

The history of progressive myoclonus epilepsies Volume 18, supplement 2, September 2016

  • [Andermann et al., 1989a] Andermann F., Berkovic S., Carpenter S., Andermann E. Viewpoints on the Ramsay Hunt syndrome. 2. The Ramsay Hunt syndrome is no longer a useful diagnostic category. Mov Disord. 1989;4:13-17.
  • [Andermann et al., 1989b] Andermann E., Andermann F., Carpenter S. Action myoclonus-renal failure syndrome: a previously unrecognised disorder unmasked by advances in nephrology. In: Fahn S., eds. Myoclonus. Advances in neurology. New York: Raven Press; 1989;43. pp. 87-103
  • [Arsov et al., 2011] Arsov T., Smith K.R., Damiano J. Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6. Am J Hum Genet. 2011;88:566-573.
  • [Bassuk et al., 2008] Bassuk A.G., Wallace R.H., Buhr A. A homozygous mutation in human causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome. Am J Hum Genet. 2008;83:572-581. PRICKLE1
  • [Batten, 1902] Batten F.E. Cerebral degeneration with symmetrical changes in the maculae in two members of a family. Trans Ophthal Soc UK. 1902;23:386-390.
  • [Berkovic et al., 1986] Berkovic S., Andermann F., Carpenter S., Andermann E., Wolfe L.S. Progressive myoclonus epilepsies: specific causes and diagnosis. N Engl J Med. 1986;315:296-305.
  • [Berkovic et al., 2008] Berkovic S.F., Dibbens L.M., Oshlack A. Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis. Am J Hum Genet. 2008;82:6.
  • [Chan et al., 2003] Chan E.M., Young E.J., Ianzano L. Mutations in cause progressive myoclonus epilepsy. Nat Genet. 2003;35:125-127. NHLRC1
  • [Diebold, 1973] Diebold K. Die erblichen myoklonisch-epileptisch-dementiellen Kernsyndrome. Berlin: Springer; 1973.
  • [Elridge et al., 1983] Elridge R., Livanainen M., Stern R., Koerber I., Wilder B.J. ‘Baltic’ myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet. 1983;2:838-842.
  • [Friedreich, 1881] Friedreich N. Paramyoclonus multiplex. Virchows Arch. 188186.
  • [Fukuhara et al., 1980] Fukuhara N., Tokiguchi S., Shirakawa K., Tsubaki T. Myoclonus epilepsy asociated with ragged-red fibers (mitochondrial abnormalities). Disease entity or a syndrome? J Neurol Sci. 1980;47:117-133.
  • [Genton et al., 1990] Genton P., Michelucci R., Tassinari C.A., Roger J. The Ramsay Hunt syndrome revisited: mediterranean myoclonus mitochondrial encephalomyopathy with ragged red fibers and Baltic myoclonus. Acta Neurol Scand. 1990;81:8-15. versus
  • [Hunt, 1921] Hunt J.R. Dyssynergia cerebellaris myoclonica – primary atrophy of the dentate system: a contribution to the pathology and symptomatology of the cerebellum. Brain. 1921;44:490-538.
  • [Janz and Christian, 1957] Janz D., Christian W. Impulsive petit-mal. Dtsch Z Nervenheilk. 1957;176:346-386.
  • [Koskiniemi, 1986] Koskiniemi M.L. Baltic myoclonus. In: Fahn S., Marsden C.D., Van Woert M., eds. Myoclonus. Advances in neurology. New York: Raven Press; 1986;43. pp. 57-64
  • [Koskiniemi et al., 1974] Koskiniemi M., Donner M., Majuri H., Haltia M., Norio R. Progressive myoclonus epilepsy: a clinical and histopathological study. Acta Neurol Scand. 1974;50:307-332.
  • [Lafora, 1911] Lafora G.R. Über das Vorkommen amyloider Körperchen im Innerender Ganglienzellen. Virchows Arch Pathol Anat. 1911;205:295-303.
  • [Lafrenière et al., 1997] Lafrenière R.G., Rochefort D.L., Chrétien N. Unstable insertion of the 5-prime flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. Nat Genet. 1997;15:298-302.
  • [Lalioti et al., 1997] Lalioti M.D., Scott H.S., Buresi C. Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature. 1997;386:847-851.
  • [Lohi et al., 2005] Lohi H., Young E.J., Fitzmaurice S.N. Expanded repeat in canine epilepsy. Science. 2005;307:81.
  • [Lundborg, 1903] Lundborg H. Die progressive myoclonusepilepsie (Unverrichts myoklonie). Uppsala: Almqvist and Wiskell; 1903.
  • [Lundborg and Runnstom, 1921] Lundborg H., Runnstom J. The Swedish nation in word and picture. Stockholm: Swedish Society for race hygiene; 1921.
  • [Marseille Consensus Group, 1990] Marseille Consensus Group. Classification of progressive myoclonus epilepsies and related diseases. Ann Neurol. 1990;28:113-116.
  • [Minassian et al., 1998] Minassian B.A., Lee J.R., Herbrick J.-A. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet. 1998;20:171-174.
  • [Minassian et al., 2016] Minassian B.A., Striano P., Avanzini G. Progressive Myoclonus Epilepsies: State-of-the-Art. Epileptic Disord. 2016;18:S1-S158. Suppl. 2
  • [Naito and Oyanagi, 1982] Naito H., Oyanagi S. Familial myoclonus epilepsy and choreoathetosis: hereditary dentatorubral-pallidoluysian atrophy. Neurology. 1982;32:798-807.
  • [Nita et al., 2016] Nita D.A., Mole S.E., Minassian B.A. Neuronal ceroid lipofuscinoses. Epileptic Disord. 2016;18:S73-S88. Suppl. 2
  • [Pennacchio et al., 1996] Pennacchio L.A., Lehesjoki A.-E., Stone N.E. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy EPM1). Science. 1996;271:1731-1733. (
  • [Rabot, 1899] Rabot, L. De la myoclonie épileptique. Medical thesis, Paris, 1899.
  • [Rapin et al., 1978] Rapin I., Goldfisher S., Katzman R., Engel J., O’Brien J.S. The cherry-red spot myoclonus syndrome. Ann Neurol. 1978;3:234-242.
  • [Roger et al., 1968] Roger J., Soulayrol R., Hassoun J. La dyssynergie cérébelleuse myoclonique (syndrome de Ramsay-Hunt). Rev Neurol. 1968;119:85-106.
  • [Roger et al., 1983] Roger J., Pellissier J.F., Bureau M., Dravet C., Revol M., Tinuper P. Le diagnostic précoce de la maladie de Lafora. Importance des manifestations paroxystiques visuelles et intérêt de la biopsie cutané. Rev Neurol. 1983;139:115-124.
  • [Rommens et al., 1989] Rommens J.M., Iannuzzi M.C., Kerem B. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989;245:1059-1065.
  • [Serratosa et al., 1999] Serratosa J.M., Gomez-Garre P., Gallardo M.E. A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum Mol Genet. 1999;8:345-352.
  • [Siintola et al., 2006] Siintola E., Partanen S., Stromme P. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain. 2006;129:1438-1445.
  • [Sleat et al., 1997] Sleat D.E., Donnelly R.J., Lackland H. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science. 1997;277:1802-1805.
  • [Steinfeld et al., 2006] Steinfeld R., Reinhardt K., Schreiber K. Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am J Hum Genet. 2006;78:988-998.
  • [Stengel, 1826] Stengel C. Beretning om et mærkeligt Sygdomstilfelde hos fire Sødskende. Account of a singular illness among four siblings in the vicinity of Røraas. Eyr (Christiana) 1, 347-352. English translation, 1982. In: Armstrong D., Koopand N., Rider J.A., eds. Ceroid lipofuscinosis (Batten's disease). Amsterdam, New York, Oxford: Elsevier Biomedical Press; 1826. pp. 17-19
  • [The International Batten Disease Consortium, 1995] The International Batten Disease Consortium. Isolation of a novel gene underlying Batten disease, CLN3. Cell. 1995;82:949-957.
  • [Tinuper et al., 1983] Tinuper P., Aguglia U., Pellissier J.F., Gastaut H. Visual ictal phenomena in a case of Lafora disease proven by skin biopsy. Epilepsia. 1983;24:214-218.
  • [Tyynela et al., 2000] Tyynela J., Sohar I., Sleat D.E. A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBO J. 2000;19:2786-2792.
  • [Unverricht, 1891] Unverricht H. Die Myoclonie. Leipzig, Vienna: Franz Deuticke; 1891.
  • [Van Bogaert, 1968] Van Bogaert L. L’épilepsie myoclonique progressive d’Unverricht-Lundborg et le problème des encéphalopathies progressives associant épilepsies et myoclonies. Rev Neurol. 1968;119:47-57.
  • [Van Heycoptenhamm and De Jager, 1963] Van Heycoptenhamm M.W., De Jager H. Progressive myoclonus epilepsy with Lafora bodies. Clinical-pathological features. Epilepsia. 1963;4:95-119.
  • [Vesa et al., 1995] Vesa J., Hellsten E., Verkruyse L.A. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature. 1995;376:584-587.
  • [Virtaneva et al., 1997] Virtaneva K., D’Amato E., Miao J. Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet. 1997;15:393-396.
  • [Weber and May, 1989] Weber J.L., May P.E. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet. 1989;44:388-396.
  • [Zeman et al., 1970] Zeman W., Donahue S., Dyken P., Green J. The neuronal ceroid-lipofuscinoses (Batten-Vogt syndrome). In: Vinken P.S., Bruyn G.W., eds. Handbook of clinical neurology. Amsterdam: Elsevier North-Holland; 1970;10. pp. 588-679